• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-基因相互作用网络构建策略甄别有治疗骨质疏松症潜力的中药。

miRNA-Gene Interaction Network Construction Strategy to Discern Promising Traditional Chinese Medicine against Osteoporosis.

机构信息

Department of Orthopedics, Chengdu Seventh People's Hospital (Tianfu District), Sichuan 610299, China.

Department of Orthopedics, The Sixth Affiliated Hospital of Xinjiang Medical University, Xinjiang 830002, China.

出版信息

Biomed Res Int. 2022 Jun 15;2022:9093614. doi: 10.1155/2022/9093614. eCollection 2022.

DOI:10.1155/2022/9093614
PMID:35757478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9217536/
Abstract

Osteoporosis is a widespread bone disease that affects million cases annually. The underlying mechanisms behind the progress of osteoporosis remain enigmatic, which limits detections of biomarkers and therapeutic targets. Hence, this study was aimed at exploring hub molecules to better understand the mechanism of osteoporosis development and discover the traditional Chinese medicine potential drugs for osteoporosis. miRNA and gene expression profiles were downloaded from Gene Expression Omnibus (GEO). Weighted correlation network analysis (WGCNA) was used to identify the key modules for osteoporosis. DIANA Tools was applied to perform pathway enrichment. A miRNA-gene interaction network was constructed, and hub miRNAs and genes were distinguished using Cytoscape software. Receiver operating characteristic (ROC) curves of hub miRNAs and genes were plotted, and correlations with hub genes and osteoporosis-associated factors were evaluated. Potential drugs for osteoporosis in Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) were screened, and molecular docking models between these drugs and target genes were showed by AutoDock tools. Two hub modules, 1 miRNA module and 1 gene module, were identified to be the most strongly correlated with osteoporosis by using WGCNA. Then, 3 KEGG pathways including focal adhesion, PI3K-Akt signaling pathway, and gap junction were shared pathways enriched with the miRNAs and genes screened out by WGCNA and differential expression analyses. Finally, after constructing a miRNA-gene interaction network, 6 hub miRNAs (hsa-miR-18b-3p, hsa-miR-361-3p, hsa-miR-484, hsa-miR-519e-5p, hsa-miR-940, and hsa-miR-1275) and 6 hub genes (THBS1, IFNAR2, ARHGAP5, TUBB2B, FLNC, and NTF3) were detected. ROC curves showed good performances of miRNAs and genes for osteoporosis. Correlations with hub genes and osteoporosis-associated factors suggested implicational roles of them for osteoporosis. Based on these hub genes, 3 natural compounds (kainic acid, uridine, and quercetin), which were the active ingredients of 192 herbs, were screened out, and a target-compound-herb network was extracted using TCMSP. Molecular docking models of kainic acid-NTF3, uridine-IFNAR2, and quercetin-THBS1 were exhibited with AutoDock tools. Our study sheds light on the pathogenesis of osteoporosis and provides promising therapeutic targets and traditional Chinese medicine drugs for osteoporosis.

摘要

骨质疏松症是一种广泛存在的骨骼疾病,每年影响着数以百万计的病例。骨质疏松症进展背后的潜在机制仍然是个谜,这限制了生物标志物和治疗靶点的检测。因此,本研究旨在探索枢纽分子,以更好地理解骨质疏松症发展的机制,并发现骨质疏松症的潜在中药治疗药物。从基因表达综合数据库(GEO)下载 miRNA 和基因表达谱。使用加权相关网络分析(WGCNA)识别骨质疏松症的关键模块。应用 DIANA Tools 进行通路富集分析。构建 miRNA-基因互作网络,使用 Cytoscape 软件区分枢纽 miRNA 和基因。绘制枢纽 miRNA 和基因的接收者操作特征(ROC)曲线,并评估与枢纽基因和骨质疏松症相关因素的相关性。从中药系统药理学数据库和分析平台(TCMSP)筛选骨质疏松症的潜在中药治疗药物,并使用 AutoDock 工具展示这些药物与靶基因之间的分子对接模型。通过 WGCNA 确定与骨质疏松症最相关的 2 个枢纽模块,1 个 miRNA 模块和 1 个基因模块。然后,通过 WGCNA 和差异表达分析筛选出的 miRNA 和基因富集了 3 个 KEGG 通路,包括粘着斑、PI3K-Akt 信号通路和缝隙连接。最后,构建 miRNA-基因互作网络后,检测到 6 个枢纽 miRNA(hsa-miR-18b-3p、hsa-miR-361-3p、hsa-miR-484、hsa-miR-519e-5p、hsa-miR-940 和 hsa-miR-1275)和 6 个枢纽基因(THBS1、IFNAR2、ARHGAP5、TUBB2B、FLNC 和 NTF3)。ROC 曲线显示 miRNA 和基因对骨质疏松症具有良好的性能。与枢纽基因和骨质疏松症相关因素的相关性表明它们对骨质疏松症具有暗示作用。基于这些枢纽基因,从 192 种草药的活性成分中筛选出 3 种天然化合物( kainic acid、uridine 和 quercetin),并使用 TCMSP 提取出靶-化合物-草药网络。使用 AutoDock 工具展示 kainic acid-NTF3、uridine-IFNAR2 和 quercetin-THBS1 的分子对接模型。我们的研究揭示了骨质疏松症的发病机制,并为骨质疏松症提供了有前途的治疗靶点和中药药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/6e77182cc0c5/BMRI2022-9093614.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/16b085d0e5f4/BMRI2022-9093614.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/9716340eb0ef/BMRI2022-9093614.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/415573f5a03d/BMRI2022-9093614.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/31f0d43b4ab9/BMRI2022-9093614.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/005823cce297/BMRI2022-9093614.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/6e77182cc0c5/BMRI2022-9093614.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/16b085d0e5f4/BMRI2022-9093614.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/9716340eb0ef/BMRI2022-9093614.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/415573f5a03d/BMRI2022-9093614.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/31f0d43b4ab9/BMRI2022-9093614.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/005823cce297/BMRI2022-9093614.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dec/9217536/6e77182cc0c5/BMRI2022-9093614.006.jpg

相似文献

1
miRNA-Gene Interaction Network Construction Strategy to Discern Promising Traditional Chinese Medicine against Osteoporosis.miRNA-基因相互作用网络构建策略甄别有治疗骨质疏松症潜力的中药。
Biomed Res Int. 2022 Jun 15;2022:9093614. doi: 10.1155/2022/9093614. eCollection 2022.
2
Identification of Hub Genes Associated with Hypertension and Their Interaction with miRNA Based on Weighted Gene Coexpression Network Analysis (WGCNA) Analysis.基于加权基因共表达网络分析(WGCNA)的高血压相关枢纽基因鉴定及其与 miRNA 的相互作用。
Med Sci Monit. 2020 Sep 5;26:e923514. doi: 10.12659/MSM.923514.
3
Identification of a Potential MiRNA-mRNA Regulatory Network for Osteoporosis by Using Bioinformatics Methods: A Retrospective Study Based on the Gene Expression Omnibus Database.基于基因表达综合数据库的生物信息学方法鉴定骨质疏松症潜在的 miRNA-mRNA 调控网络:一项回顾性研究。
Front Endocrinol (Lausanne). 2022 May 10;13:844218. doi: 10.3389/fendo.2022.844218. eCollection 2022.
4
Comprehensive analysis of miRNA-mRNA regulatory network and potential drugs in chronic chagasic cardiomyopathy across human and mouse.慢性恰加斯心肌病中人类和小鼠的 miRNA-mRNA 调控网络及潜在药物的综合分析
BMC Med Genomics. 2021 Nov 29;14(1):283. doi: 10.1186/s12920-021-01134-3.
5
Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.通过通路富集分析和枢纽基因- microRNA网络揭示多囊卵巢综合征(PCOS)的关键生物标志物和治疗药物
Iran J Pharm Res. 2023 Nov 20;22(1):e139985. doi: 10.5812/ijpr-139985. eCollection 2023 Jan-Dec.
6
Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.基于网络药理学的黄芪治疗糖尿病肾病的 miRNA 表达研究。
Medicine (Baltimore). 2022 Feb 4;101(5):e28747. doi: 10.1097/MD.0000000000028747.
7
An integrated bioinformatic analysis of microarray datasets to identify biomarkers and miRNA-based regulatory networks in leishmaniasis.通过对微阵列数据集进行综合生物信息学分析,确定利什曼病的生物标志物和 miRNA 调控网络。
Sci Rep. 2024 Jun 5;14(1):12981. doi: 10.1038/s41598-024-63462-5.
8
Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.利用miRNA分析和生物信息学工具对膀胱癌中的关键miRNA和靶基因进行研究。
Mol Biol Rep. 2014 Dec;41(12):8127-35. doi: 10.1007/s11033-014-3713-5. Epub 2014 Sep 5.
9
Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.利用生物信息学分析非小细胞肺癌患者血浆中潜在的 miRNA-mRNA 调控网络。
BMC Cancer. 2022 Mar 21;22(1):299. doi: 10.1186/s12885-022-09281-1.
10
Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.微小RNA与基因表达谱的综合分析揭示了一个与肝纤维化相关的功能调节模块。
Gene. 2017 Dec 15;636:87-95. doi: 10.1016/j.gene.2017.09.027. Epub 2017 Sep 14.

引用本文的文献

1
LncRNA SDCBP2-AS1 is a putative biomarker for postmenopausal osteoporosis and promotes osteogenic differentiation of BMSCs by regulating miR-361-3p.长链非编码RNA SDCBP2-AS1是绝经后骨质疏松症的一种潜在生物标志物,并通过调控miR-361-3p促进骨髓间充质干细胞的成骨分化。
Hereditas. 2025 Jul 10;162(1):124. doi: 10.1186/s41065-025-00494-5.
2
Network study of miRNA regulating traumatic heterotopic ossification.微小RNA调控创伤性异位骨化的网络研究
PLoS One. 2025 Feb 11;20(2):e0318779. doi: 10.1371/journal.pone.0318779. eCollection 2025.
3
Integration of bioinformatics and machine learning approaches for the validation of pyrimidine metabolism-related genes and their implications in immunotherapy for osteoporosis.

本文引用的文献

1
Mechanism of dexmedetomidine regulating osteogenesis-angiogenesis coupling through the miR-361-5p/VEGFA axis in postmenopausal osteoporosis.右美托咪定通过 miR-361-5p/VEGFA 轴调控绝经后骨质疏松症成骨-血管生成偶联的机制。
Life Sci. 2021 Jun 15;275:119273. doi: 10.1016/j.lfs.2021.119273. Epub 2021 Feb 22.
2
Silencing of miR-483-5p alleviates postmenopausal osteoporosis by targeting SATB2 and PI3K/AKT pathway.沉默 miR-483-5p 通过靶向 SATB2 和 PI3K/AKT 通路缓解绝经后骨质疏松症。
Aging (Albany NY). 2021 Feb 17;13(5):6945-6956. doi: 10.18632/aging.202552.
3
Quercetin promotes osteogenic differentiation and antioxidant responses of mouse bone mesenchymal stem cells through activation of the AMPK/SIRT1 signaling pathway.
生物信息学和机器学习方法的整合用于验证嘧啶代谢相关基因及其在骨质疏松症免疫治疗中的意义。
BMC Musculoskelet Disord. 2024 May 22;25(1):402. doi: 10.1186/s12891-024-07512-z.
4
A Complex Heterogeneous Network Model of Disease Regulated by Noncoding RNAs: A Case Study of Unstable Angina Pectoris.非编码 RNA 调控疾病的复杂异质网络模型:以不稳定型心绞痛为例。
Comput Intell Neurosci. 2022 Dec 23;2022:5852089. doi: 10.1155/2022/5852089. eCollection 2022.
槲皮素通过激活AMPK/SIRT1信号通路促进小鼠骨髓间充质干细胞的成骨分化和抗氧化反应。
Phytother Res. 2021 May;35(5):2639-2650. doi: 10.1002/ptr.7010. Epub 2021 Jan 9.
4
Defactinib attenuates osteoarthritis by inhibiting positive feedback loop between H-type vessels and MSCs in subchondral bone.地法替尼通过抑制软骨下骨中H型血管与间充质干细胞之间的正反馈回路来减轻骨关节炎。
J Orthop Translat. 2020 May 19;24:12-22. doi: 10.1016/j.jot.2020.04.008. eCollection 2020 Sep.
5
MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA.miR-16-5p 通过直接靶向 VEGFA 来调节绝经后骨质疏松症。
Aging (Albany NY). 2020 May 19;12(10):9500-9514. doi: 10.18632/aging.103223.
6
Osteoporosis-decreased extracellular matrix stiffness impairs connexin 43-mediated gap junction intercellular communication in osteocytes.骨质疏松症——细胞外基质硬度降低会损害骨细胞中连接蛋白 43 介导的缝隙连接细胞间通讯。
Acta Biochim Biophys Sin (Shanghai). 2020 May 26;52(5):517-526. doi: 10.1093/abbs/gmaa025.
7
High Glucose Downregulates Connexin 43 Expression and Its Gap Junction and Hemichannel Function in Osteocyte-like MLO-Y4 Cells Through Activation of the p38MAPK/ERK Signal Pathway.高糖通过激活p38丝裂原活化蛋白激酶/细胞外信号调节激酶信号通路下调骨细胞样MLO-Y4细胞中连接蛋白43的表达及其缝隙连接和半通道功能。
Diabetes Metab Syndr Obes. 2020 Feb 26;13:545-557. doi: 10.2147/DMSO.S239892. eCollection 2020.
8
Distinct Subsets of Noncoding RNAs Are Strongly Associated With BMD and Fracture, Studied in Weight-Bearing and Non-Weight-Bearing Human Bone.在负重和非负重人体骨骼中研究发现,非编码RNA的不同亚群与骨密度和骨折密切相关。
J Bone Miner Res. 2020 Jun;35(6):1065-1076. doi: 10.1002/jbmr.3974. Epub 2020 Mar 2.
9
PSMC6 promotes osteoblast apoptosis through inhibiting PI3K/AKT signaling pathway activation in ovariectomy-induced osteoporosis mouse model.PSMC6 通过抑制卵巢切除诱导骨质疏松症小鼠模型中 PI3K/AKT 信号通路的激活促进成骨细胞凋亡。
J Cell Physiol. 2020 Jul;235(7-8):5511-5524. doi: 10.1002/jcp.29261. Epub 2020 Feb 4.
10
MiR-152 influences osteoporosis through regulation of osteoblast differentiation by targeting RICTOR.miR-152 通过靶向 RICTOR 调控成骨细胞分化影响骨质疏松症。
Pharm Biol. 2019 Dec;57(1):586-594. doi: 10.1080/13880209.2019.1657153.